- Home
- VTGN vs NTIP Comparison
VTGN vs NTIP Comparison
Compare VTGN & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.66
N/A
Current Price
$1.30
Company Overview
Basic Information| Metric | VTGN | NTIP |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.8M | 32.0M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | VTGN | NTIP |
|---|---|---|
| Price | $0.66 | $1.30 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $0.90 | N/A |
| AVG Volume (30 Days) | ★ 6.2M | 19.0K |
| Earning Date | 02-12-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 7.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $721,000.00 | $150,000.00 |
| Revenue This Year | $54.26 | N/A |
| Revenue Next Year | $478.23 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $1.16 |
| 52 Week High | $5.14 | $1.90 |
Technical Indicators
Market Signals| Indicator | VTGN | NTIP |
|---|---|---|
| Relative Strength Index (RSI) | 24.05 | 41.66 |
| Support Level | $0.63 | $1.32 |
| Resistance Level | $0.77 | $1.42 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 17.96 | 7.69 |
Price Performance
Historical Comparison VTGN
NTIP
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.